Pacific Channel   Search
Biomedical Venture Development and Corporate Advisory Register  Login
Home
About Us
Our Team
Our Services
Investment Opportunities
Publications
Articles
Pacific Biotech Bulletin
Our Affiliates
Portfolio Companies
Ingredient Solutions
Contact Us
Events
News

Our Team

Our team has extensive collective experience and knowledge in academic research, executive and corporate management, government and international trade. The managing partners of Pacific Channel’s US-based sister company 
The Channel Group  have formed, managed and grown entrepreneurial life sciences companies for decades.

Pacific Channel


 
Brent S. Ogilvie, BSc. (Bio.), MBA | Email Brent

Call me!

  • Founder and Director of Pacific Channel Limited, which is a venture development and investment company specialising in technology and life science-based industries.
  • Foundation CEO (Part-time) of Androgenix Limited, a biotechnology company that applies genomic technology for the development products with application in the world-wide livestock industry.
  • Executive Director of Ecodiesel Limited, which has developed a proprietary manufacturing process to convert tallow (purified animal fat) into biodiesel at a capital cost several-fold lower and at a lower operating cost than known alternative processes.  
  • Executive Director of Sleep Limited
  • Executive Director of Ingredient Solutions Limited
  • Former NZ Consul & Trade Commissioner to New York - Life Sciences
  • Former Trade NZ Sector Leader – Life Sciences & Agritechnologies
  • Former Product Manager of a Fletcher Challenge subsidiary
  • Former Technical consultant to NZ start-ups

Mitali Purohit, BSc. (Bio.), MBE. (Hons)

  • Mitali Purohit is a Research Analyst at Pacific Channel Limited
  • Through Pacific Channel activities as a seed investor, Ms. Purohit serves as a Chief Operating Officer for Breathe Easy Ltd, a biotechnology company that is developing a treatment for Cystic Fibrosis
  • Ms Purohit has experience in assessing investment opportunities and assisting early stage life-science and engineering based ventures to become investment ready
  • Ms Purohit’s principal interest is in technology commercialization, especially opportunity analysis, marketing and business development
  • Her Master’s thesis investigated ingredient co-branding as a strategy option for a New Zealand supplier of functional ingredients

The Channel Group LLC

Robert J. Beckman

  • Managing Partner - The Channel Group
  • Current Board Member of private and public medical companies, including EZ EM Corporation (Nasdaq: EZEM)
  • Current Trustee of New York Medical College
  • Founder and immediate past CEO of Intergen Company, a multinational life sciences company involved in pharmaceuticals, diagnostics, and discovery tools
  • Former Vice President, Marketing Services and Vice President and General Manager of Biochemical and Diagnostic Division of Revlon Health Care
    • A founder, past Chairman and long-term Board Member of BIO (Biotechnology Industry Organisation) and the New York Biotechnology Association
  • Co-Author of Bold Steps – New Horizons , an analysis and plan for advancing Biotechnology in New Zealand

Allan R. Goldberg, Ph.D.

  • Managing Partner - The Channel Group
  • Founder of several start-ups, including Zystor Therapeutics, Inc., which received a venture financing of approximately US $10 million where he serves as a Member of the Board of Directors
  • Member of the Board of Directors of SuperGen Inc. (NasdaqNM:SUPG)
  • Former Professor of Virology at the Rockefeller University
  • Founder, CSO and CEO of Innovir Laboratories, Inc., a biopharmaceutical company focused on development of RNA drugs Took Innovir public on Nasdaq.
  • Co-Author of Bold Steps – New Horizons, an analysis and plan for advancing Biotechnology in New Zealand

Philip N. Sussman

  • Managing Partner - The Channel Group
  • Member of Senior Management (Head of Business Development, CFO, and CEO) at several life sciences companies including Perlegen Sciences, Inc., Memory Pharmaceuticals Corp., and Cadus Pharmaceutical Corp.
  • Took company public on Nasdaq while CFO
  • Completed strategic alliances with major pharmaceutical companies including AstaZeneca AB, Bristol-Myers Squibb Co., Eli Lilly & Co., GlaxoSmithKline plc, Pfizer Inc., Solvary Pharmaceuticals B.V., and Unilever plc, transactions that provided funding in excess of US $100 million
  • Director of Business Development at Ciba-Geigy Corp.’s Pharmaceuticals Division
  • Advisor to PsychoGenics Inc., Automated Cell, Inc., and SCIUS Capital Group LLC

  
Auckland-Brilliant
4 Business
Minimize

More...
 

Grant Guides

Read about Pacific Channel's guide to accessing international grants and contact us for more information. More...

Why invest in
Biotechnology?

The global life sciences industry is one of the greatest sources of innovation available today. More...

Why invest in NZ
Biotechnology
Companies?

New Zealand has a history of excellence in life sciences research in food and agriculture More...

Copyright 2006 Pacific Channel   Terms Of Use  Privacy Statement